
Kanjinti (Trastuzumab-anns)
KANJINTI is a HER2/neu receptor antagonist indicated for: the treatment of HER2 overexpressing breast cancer. (1.1, 1.2) the treatment of HER2 overexpressing metastatic gastric or…
KANJINTI is a HER2/neu receptor antagonist indicated for: the treatment of HER2 overexpressing breast cancer. (1.1, 1.2) the treatment of HER2 overexpressing metastatic gastric or…
KANUMA is indicated for the treatment of patients with a diagnosis of Lysosomal Acid Lipase (LAL) deficiency. KANUMA is a hydrolytic lysosomal cholesteryl ester and…
1.1 Healing of Erosive Esophagitis KAPIDEX is indicated for healing of all grades of erosive esophagitis (EE) for up to 8 weeks.1.2 Maintenance of Healed Erosive Esophagitis KAPIDEX is indicated to maintain healing of EE for up to 6 months. 1.3…
KAPSPARGO Sprinkle is a beta 1 -adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and…
KAPVAY (clonidine hydrochloride) extended-release is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2023. All Rights Reserved.